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The ﬂuoride has volcanic activity and abundantly exists in environment combining with other elements as ﬂuoride compounds.
Recent researches indicated that the molecular mechanisms of intracellular ﬂuoride toxicity were very complex. However, the
molecular mechanisms underlying the eﬀects on gene expression of chronic ﬂuoride-induced damage is unknown, especially the
detailed regulatory process of mitochondria. In the present study, we screened the diﬀerential expression ESTs associated with
ﬂuorosis by DDRT-PCR in rat liver. We gained 8 genes, 3 new ESTs, and 1 unknown function sequence and ﬁrstly demonstrated
that microsomal glutathione S-transferase 1 (MGST1), ATP synthase H+ transporting mitochondrial F0 complex subunit C1,
selenoprotein S, mitochondrial IF1 protein, and mitochondrial succinyl-CoA synthetase alpha subunit were participated in
mitochondria metabolism, functional and structural damage process caused by chronic ﬂuorosis. This information will be very
helpful for understanding the molecular mechanisms of ﬂuorosis.
1.Introduction
The ﬂuoride has volcanic activity and abundantly exists
in environment combining with other elements as ﬂuoride
compounds. With the development of the world economy,
more and more organoﬂuorine compounds are increasingly
used. These compounds have a wide range of functions
and can serve as agrochemicals, pharmaceuticals, refriger-
ants, pesticides, surfactants, ﬁre-extinguishing agents, ﬁbers,
membranes, ozone depletors, and insulating materials [1, 2].
At the same time, in last decade, the ﬂuoride eﬀects have
resurfaced due to the awareness that this element interacts
with cellular systems even at low doses. Excessive ﬂuoride
intake over a long period of time may result in a serious pub-
lic health problem called ﬂuorosis, which is characterized by
dental mottling and skeletal manifestations such as crippling
deformities, osteoporosis, and osteosclerosis [3].
In recent years, metabolic, functional, and structural
damage caused by chronic ﬂuorosis have been reported in
many tissues. Fluoride can induce oxidative stress and mod-
ulateintracellularredoxhomeostasis,lipidperoxidation, and
p r o t e i nc a r b o n y lc o n t e n t ,a sw e l la sa l t e rg e n ee x p r e s s i o n
and cause apoptosis. Genes modulated by ﬂuoride include
those related to the stress response metabolic enzymes, the
cell-cell communications, and signal transduction [1]. In
most cases, ﬂuoride acts as an enzyme inhibitor, but ﬂuoride
ions can occasionally stimulate enzyme activity. Research
data strongly suggest that ﬂuoride inhibits protein secretion
and/or synthesis and that it inﬂuences distinct signaling
pathways involved in proliferation and apoptosis including
themitogen-activatedproteinkinase(MAPK),p53,activator
protein-1 (AP-1), and nuclear factor kappa B (NF-κB)
pathways [4–6]. However, information about the molecular
mechanism of ﬂuoride-induced tissue damage is almost
unknown. Some studies point out that the mitochondria are
the key intracellular targets for diﬀerent stressors including
ﬂuoride [7]. Fluoride alters the activity of many mito-
chondria-rich cells such as those of the human kidney and
the rat liver [8, 9], but the molecular mechanisms of chronic
ﬂuoride-induced mitochondrial damage are scarce. As an
important detoxiﬁcation organ, liver plays a pivotal role on
resolving ﬂuorosis eﬀects. In the present study, in order to2 Comparative and Functional Genomics
get a deeper understanding of the molecular mechanisms
underlying the eﬀects of ﬂuoride on mitochondrial gene
expression and metabolism, we screened diﬀerential display
genes or expressed sequence tags(ESTs) involved in Sprague-
Dawley rats with ﬂuorosis.
2.MaterialsandMethods
2.1. Animals and Fluoride Exposures. The protocol for the
studywasreviewedandapprovedbytheInstitutionalAnimal
Use and Care Committees of Jiangsu University. The male
Sprague-Dawley rats (n = 30) were received three week
after weaning, an age at which all regions of the central
nervous system are rapidly developing. All animals were
housed in stainless-steel cages suspended in stainless-steel
racks with the humidity ranged from 30 to 55%, and the
room temperature remained between 22 and 25◦C, fed with
a standard pellet diet, and given distilled water ad libitum.
The animals were allowed to acclimatize to the laboratory
conditions for four days before experiments began.
The rats were weighed and randomly divided into 2
groups (15/group). The ﬁrst group animals were injected
i.p. with aqueous NaF (20mg/kg/body weight/day) selected
on the basis of the LD50 value of ﬂuoride, which is
51.6mg/kg body weight/day in mice and maintained for 30
days. The second group served as control and was injected
mammalian physiological saline. The NaF solution (30mL)
was prepared fresh each day in double distilled water. At
the end of the 30-day treatment, the animals were killed
by decapitation, the brains were rapidly dissected, and the
hippocampus removed. The tissue was immediately frozen
in liquid nitrogen and stored at −80◦C until use. The exper-
iments were performed in accordance with the regional legal
regulations. The body weight of each animal was weighed
before treatment, and weighed every 10 days. The F-levels
in serum were determined [10] by using a CSB-F-I ﬂuoride
ion electrode (Changsa Analysis Instrumentation, China) to
conﬁrm chronic ﬂuorosis.
2.2. Total RNA Extraction and RNA Pools. Total RNA of liver
samples was extracted using Trizol kit (Invitrogen, Carlsbad,
USA) according to the manufacturer’s instructions. To
remove any contaminated genomic DNA from the RNA
samples,25μLoftotalRNAwastreatedwithanequalvolume
of RNase-free DNase-I mixture (Promega, Madison, WI,
USA), and the whole mixture was incubated at 37◦Cf o r
30min. Subsequently, the mixture was subjected to phenol-
chloroform extraction followed by ethanol precipitation.
The concentration of puriﬁed RNA was determined by
absorbance at 260nm. An RNA pool containing equal
amount RNA of three individuals from the same breed was
established. The RNA samples were stored at −70◦C.
2.3. Primers. The cDNA primers of three anchored primers
of H-T11A, H-T11G and H-T11C and eight arbitrary primers
of P1–P8 were designed according to the third generation
primers of GenHunter Company. The 3  end anchored
primers were
H-T11G: 5 -AAGCTTTTTTTTTTTG-3 ;
H-T11C: 5 -AAGCTTTTTTTTTTTC-3;
H-T11A: 5 -AAGCTTTTTTTTTTTA-3.
The 5  end arbitrary oligonucleotide primers were:
P1: 5 -TGCCGAAGCTTTGGTGTC-3 ;
P2: 5 -TGCCGAAGCTTTGGTACC-3 ;
P3: 5 -TGCCGAAGCTTTGGTAGC-3 ;
P4: 5 -TGCCGAAGCTTTGGTATG-3 ;
P5: 5 -TGCCGAAGCTTTGGTCAC-3 ;
P6: 5 -TGCCGAAGCTTTGGTCAG-3 ;
P7: 5 -TGCCGAAGCTTTGGTCTG-3 ;
P8: 5 -TGCCGAAGCTTTGGTCTC-3 .
2.4. Reverse Transcription. A1 μLo f3   anchored primer
(1μmol/L) was combined with 4μL( 1 μg/μL) RNase-free
DNase I-treated RNA samples and 1μL of 10mmol/L dNTP
mix, the mixture was adjusted to a ﬁnal volume of 11μL
by adding DEPC-treated water. Then it was incubated for
5min at 65 ◦C followed by cooling on ice for 2min. First-
strand synthesis was initiated by mixing the mixture with
1μL (50 units/μL) M-MLV reverse transcriptase (Invitrogen)
in a ﬁnal volume of 8μL mix containing 2μLo f1 0× RT
buﬀer (200mmol/L Tris-HCl (pH 8.4), 500mmol/L KCl),
4μL of 25mmol/L MgCl2,a n d2μLo f0 . 1m o l / LD T T .T h e
reverse transcription reaction was carried out at 42◦Cf o r
1h, then terminated by heating at 70◦Ci naw a t e rb a t h
for 15min. The reverse transcription product of cDNA was
stored at −20◦C.
2.5. DD-PCR. A1 μL of the reverse transcription product
was added to 24μL of PCR solution containing 20μmol/L
dNTPs, 1.5mmol/L MgCl2,1 Uo fT a qD N Ap o l y m e r a s e
(Promega), 20μmol/L H-T11N (H-T11G/H-T11C/H-T11A)
primer used for RT, and 10μmol/L of one of eight arbitrary
primers. The PCR reaction was carried out on Mastercy-
cler 5333 (Eppendorf AG, Hamburg, Germany). The PCR
parameters were as follows: initial denaturation at 94◦Cf o r
5min; followed by one cycle of denaturation at 94◦Cf o r
30s, annealing at 40◦C for 2min, extension at 72◦Cf o r
2min; followed by 35 cycles of denaturation at 94◦Cf o r3 0s ,
annealing at 60◦C for 2min, extension at 72◦C for 2min;
with a ﬁnal extension step at 72◦C for 5min. The ampliﬁed
fragments of DDRT-PCR were separated by electrophoresis
using 8% polyacrylamide gels (acrylamide:bisacrylamide =
39:1). Then, the PCR products were visualized by silver
staining and photographed and analyzed using an AlphaIm-
ager 2200 and 1220 Documentation and Analysis Systems
(Alpha Innotech Corporation, San Leandro, CA, USA).
2.6. Reverse Northern Dot Blot Analysis. Reverse Northern
dot blotting was carried out according to the instruction
manual of DIG-HIGH Prime DNA labeling and detection
starter kit I (Roche, Penzberg, Germany). In brief, 1μgo f
template DNA was denatured by heating in a boiling water
bath for 10min and quickly chilling in an ice/water bath,
then DIG-HIGH Prime was mixed and incubated at 37◦C
for 1h, and the reaction was stopped by adding 2μLo f
0.2mol/L EDTA (pH 8.0). Subsequently, the RT productsComparative and Functional Genomics 3
were ﬁxed on the nylon membranes positively charged by
UV crosslinking and were then hybridized in DIG Easy
Hyb (10mL/100cm2) containing DIG-labeled DNA probe
at appropriate hybridization temperature for 20h. After
hybridization and stringency washes, the nylon membranes
were incubated in 100mL blocking solution for 30min and
in 20mL antibody solution for 30min. Then it was detected
in freshly color substrate solution in the dark after washing
two times in 100mL washing buﬀer for 15min, and the
reaction will be completed after 16h and terminated by
50mL TE buﬀer for 5min.
2.7. Puriﬁcation, Sequencing, and Analysis of Diﬀerential
Bands. Diﬀerential fragments from 100bp to 1200bp were
excised from the gels, extracted by boiling in 100μLo f
distilled water, puriﬁed with a DNA puriﬁcation system
(Promega), reampliﬁed using the same primer correspond-
ing to cDNA display. The PCR ampliﬁcation conditions were
as follows: initial denaturation at 94◦C for 3min; followed
by 33 cycles of denaturation at 94◦C for 2min, annealing
at 55◦C for 2min, extension at 72◦C for 2min; with a
ﬁnal extension at 72◦C for 5min. The 25μL of the reampli-
ﬁed PCR sample along with 5μL of gel loading buﬀer was
analyzed on 1.5% agarose/EtBr gel in 1 × TAE (40mmol/L
Tris base, 20mmol/L acetic acid, 2mmol/L EDTA pH
8.0). The PCR bands of interest were cut from the gels
under UV illumination. The DNA was puriﬁed using DNA
extraction kit (Qiagen, Hilden, Germany). The puriﬁed
diﬀerential bands were ligated into the pGEM-T Easy vector
(Promega) according to manufacturer
 s instructions and
transformed into Escherichia coli DH5α competence cells.
The positive clones were sequenced using an automatic ABI
3730 sequencer (Perkin Elmer Applied Biosystems, Foster
City, CA, USA) by Shanghai Invitrogen Biotechnology Ltd.
Co. (Shanghai, China) and analyzed in GenBank by BLAST.
3. Results
3.1. Extraction and Reverse Transcription of Total RNA. We
collected the livers at the same conditions except ﬂuoride
treatment for extracting the RNA. The gel proﬁle of RNA
showed that two bands of 18S and 28S were clear and could
be used for reverse transcription.
3.2. DD-PCR. We displayed the diﬀerent bands of two kinds
of cDNA using 24 primer pairs consisting of 3 anchored
primers and 8 arbitrary primers. The partial results were
shown in Figure 1. At last 1532 bands were detected on
statistics, and 36 bands were recovered and sequenced based
on their diﬀerences (lack, density, and size). The recovered
diﬀerential bands were reampliﬁed with the same anchor
primer and arbitrary primer using the recovered products as
templates. However, some of the recovered bands could not
be perfectly ampliﬁed because of the false positive.
3.3. Reverse Northern Dot Blot. In order to eliminate the dis-
ruption of false positive bands, reverse northern was carried
out to validate diﬀerential bands. 36 diﬀerential bands of













Figure 1: Diﬀerential display proﬁles from diﬀerent primer combi-
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Figure 2:Partialresultsofreversenortherndotblotsfordiﬀerential
display bands. +: positive control; −: false control. 1–14: the results
of dot blot of bands, visible dot represents positive result, and no
dot represents false result.
PCR ampliﬁcations were blotted on two nylon membranes
and hybridized with probes of liver cDNA. The results
showed that 13 positive blots were detected (Figure 2).
3.4. Sequence Analysis of Diﬀerential Bands. All the13 pos-
itive bands detected by reverse northern dot blot were
sequenced and analyzed in GenBank by BLAST. The align-
ment standards include that the ESTs length should be
more than 100bp, the E value should be less than 0, and
the identity should exceed 90%. The results were listed
in Table 1. The BLAST results demonstrated that 8 genes
including microsomal glutathione S-transferase 1, acyl-CoA
synthetase long-chain family member, ATP synthase H+
transporting mitochondrial F0 complex subunit C1, hap-
toglobin, selenoprotein S, mitochondrial IF1 protein, acyl-
CoA synthetase long-chain family member, mitochondrial
succinyl-CoA synthetase alpha subunit, 3 new ESTs, and 1
unknown function sequence were diﬀerential expressed.
4. Discussion
Several molecular strategies including microarray analysis,
in vivo expression technology (IVET), DDRT-PCR, and
signature-tagged mutagenesis have been used to identify
diﬀerential expression genes in all kinds of organs, tissues,
and individuals. Although DDRT-PCR was originally known4 Comparative and Functional Genomics





bp Copies BLAST results Score E value Identities
(1) NM 134349.3 183 1 Microsomal glutathione S-transferase 1 307 bits (166) 1e−80 170/172 (99%)
(2) NM 012820.1 324 1 Acyl-CoA synthetase long-chain family member 540 bits (292) 2e−150 297/299 (99%)
(3) New EST 176 1 No signiﬁcant similarity found / / /
(4) AI029143.1 317 1 UI-R-C0-ip-g-08-0-UI 549 bits (297) 4e−153 304/307 (99%)
(5) NM 017311.1 266 1 ATP synthase, H+ transporting, mitochondrial F0
complex, subunit C1 444 bits (240) 2e−121 240/240 (100%)
(6) NM 012582.2 332 1 Haptoglobin 586 bits (317) 3e−164 319/320 (99%)
(7) NM 173120.2 318 2 Selenoprotein S 558 bits (302) 6e−156 309/312 (99%)
(8) L07806.1 483 1 Mitochondrial IF1 protein 761 bits (412) 0.0 412/412 (100%)
(9) New EST 283 1 No signiﬁcant similarity found / / /
(10) NM 012820.1 196 1 Acyl-CoA synthetase long-chain family member 540 bits (292) 2e−150 297/299 (99%)
(11) New EST 311 1 No signiﬁcant similarity found / / /
(12) J03621.1 455 1 Mitochondrial succinyl-CoA synthetase alpha
subunit 797 bits (431) 0.0 433/434 (99%)
that it had highly false positive bands, recent modiﬁcations
have allowed this technique to be used again perfectly. In this
study, by using a novel and modiﬁed DDRT-PCR technique,
the primers were the third generation DDRT-PCR primers
consisting of both anchored and arbitrary primers, which
have Hind enzyme site. The number of primers also reduces
to three anchored primers and eight arbitrary primers. This
primer combination had proved by computer analysis to
possess the ability to include all mRNAs in certain stage
of some cell development, which makes it easier for next
operation and treatment. As in most described DDRT-PCR
protocols, total RNA was used as the starting material. In the
present study, to exclude partial degradation, we tested total
RNA preparation with DNase I to reduce artifacts caused by
possible contamination with genomic DNA. To reduce the
rate of mismatches that occur with low stringency annealing
during subsequent PCR cycles, we followed the strategy
published by Zhao et al. [11], the cycle procedure was only
one initial cycle with low stringency annealing temperature
(40◦C), and followed by 35 high stringency PCR cycles with
annealing temperature (60◦C). This method signiﬁcantly
improved the reproducibility of band patterns.
According to the results of the sequence BLAST, we
gained 8 genes, 3 new ESTs, and 1 unknown function
sequence and ﬁrstly demonstrated that microsomal glu-
tathione S-transferase 1 (MGST1), ATP synthase H+ trans-
portingmitochondrialF0 complexsubunitC1,selenoprotein
S, mitochondrial IF1 protein, and mitochondrial succinyl-
CoA synthetase alpha subunit were participated in mito-
chondria metabolism, functional and structural damage
process caused by chronic ﬂuorosis.
Membrane-bound microsomal GST (MGST1), geneti-
cally diﬀerent from the cytosolic GSTs, is a homotrimer
with one thiol group (Cys49) per subunit and is activated
by thiol alkylation, by disulﬁde bond formation or sulfenic
acid formation, and by other mechanisms [10, 12–15].
mtMGST1, a similar type of microsomal MGST1, is also
activated by modiﬁcation of thiol to a mixed disulﬁde bond
(S-glutathionylation) and by a disulﬁde-linked mtMGST1
dimer in oxidative stress in vivo and in vitro. It was also
clariﬁed that the activation of mtMGST1 contributes to
cytochrome c release from mitochondria [16]. MGST1 is
activated by oxidative stress, and mtMGST1 is activated
through mixed disulﬁde bond formation that contributes to
cytochrome c release from mitochondria through the mito-
chondrial permeability transition (MPT) pore [16]. Fluoride
can induce an increase in the release of cytochrome c
from the mitochondria to the cytosol and straightly enter
in mitochondria metabolism. In addition, NADPH, and
ATP-depended activation of MGST1, which showed the
relationship between MGST1 and cellular respiration [17].
According to these references, we could demonstrate that
MGST1 participated in the cellular eﬀects by ﬂuorosis on
cellular respiration and inner membrane permeability and
membrane potential.
ATPsynthaseH+ transportingmitochondrialF0 complex
subunit C1 is an isoform of mtATP synthase subunit 9. F0F1-
ATP synthase, also known as ATP synthase, is composed
of three parts: the catalytic sector F1, consisting of ﬁve
subunits (3α;3 β; γ; δ; ε), the H+ translocating sector F0,
and a stalk connecting F1 with F0, both consisting of a
variable number of subunits [18–20]. In the F0F1-ATP syn-
thase complex, in addition to the F1-γ and the F0I-PVP (b)
subunits [19], also the oligomycin-sensitivity-conferring
protein (OSCP) is involved in the coupling of the F1 catalytic
activity to transmembrane proton translocation by F0 [21].
It has been shown that the F0F1-ATP synthase represents
one of the sites of T3 action [22, 23]. It is no doubt that
ATP synthase expression will be in diﬀerential level between
ﬂuorosis rat and control rat. Each process including cellular
respiration, ROS generation, inner membrane permeability,
calcium and phosphate transportation, glucose transport,
and cell apoptosis need ATP synthase and energy. Obviously
we should know its importance in resistant to ﬂuorosis.Comparative and Functional Genomics 5
Another gene we screened, mitochondrial IF1 protein, is
associated to ATPase activity. IF1 is present in animals [24,
25], yeasts [26, 27], and plants [28, 29]. Its structure is essen-
tially α-helical [30]. Pioneering investigations have shown
that bovine IF1 (bIF1) lacking the ﬁrst 16 residues after
partial enzymatic digestion retains the capacity to inhibit
ATPase activity [31]. It has been later reported that the
minimal inhibitory sequence consists of residues 22–46 [32]
or 14–47 [23] in bovine and of residues 17–41 in yeasts [32].
Deletion of the ﬁrst 17 residues in mammal IF1 resulted in
a still inhibitory peptide but with a very low aﬃnity for ATP
synthase, whereas conﬂicting results were reported concern-
ing the removal of the ﬁrst 21 residues [32–34]. Importantly,
the visible part in N-terminus of IF1 (residues 8–21) appears
wrapped around the γ subunit and also interacting with the
α-subunit. This ﬁnding raises the problem of the role of
the Nter part of IF1 in the diﬀerent steps of the inhibitory
process. IF1 peptides partially truncated in Nter have been
shown to inhibit ATPase activity after several minutes of
incubation [33, 34], but in vivo the inhibitory peptide very
rapidly responds to pmf variations, as shown by the absence
of ATP hydrolysis activity immediately after adding an
uncoupler to mitochondria [35]. IF1 appears to limit mi-
tochondrial ROS generation, limiting autophagy which is
increased by IF1 knockdown [36].
We screened mitochondrial succinyl-CoA synthetase
alpha subunit (mtSCS), and its function is also correlated to
ATPase activity. SCS is a Krebs cycle enzyme that catalyzes
substrate-level phosphorylation in the forward direction and
replenishes succinyl-CoA for ketone body catabolism and
porphyrin biosynthesis in the reverse direction [37–39]. In
mammals two isoforms of SCS have been identiﬁed: one
speciﬁc for ADP/ATP and another speciﬁc for GDP/GTP. In
some species (i.e., Escherichia coli), SCS is not speciﬁc, using
either the ATP or GTP [39]. SCSα has a well-documented
histidine phosphorylation site but has also been shown to
bind phosphate in its dephosphorylated form as a means of
stabilizing the complex [39]. Furthermore, SCS can generate
ATP in the absence of a proton motive force in the inner
membrane, potentially playing a role in maintaining matrix
ATPlevelsunderenergy-limitedconditions,suchastransient
hypoxia. Inorganic phosphate (Pi), a putative cytosolic sig-
nalingmolecule,playsamultifacetedroleintheregulationof
mitochondrial metabolism. Pi can alter the free concentra-
tion of Mg2+ and Ca2+ ions, increase mitochondrial volume,
inﬂuence the mitochondrial transition pore, and directly
modify the activity of several Krebs cycle dehydrogenases
[40–43].
Selenoprotein S has recently been described as an endo-
plasmic reticulum (ER) and plasma membrane-located
selenoprotein involved in the physiologic adaptation to ER
stress [44, 45]. The SELS gene is known to be expressed
in a wide variety of tissues and cell types, including tissues
important for glycemic control such as adipose tissue,
muscle, and liver [44, 45]. Some studies have shown that
SELS genotype is associated with circulating levels of proin-
ﬂammatory cytokines, such as tumor necrosis factor-α
(TNF-α) and interleukin-1β (IL-1β), suggesting that SELS
plays a role in inﬂammation [46].
5. Conclusion
Microsomal glutathione S-transferase 1 (MGST1), ATP
synthase H+ transporting mitochondrial F0 complex sub-
unit C1, selenoprotein S, mitochondrial IF1 protein, and
mitochondrial succinyl-CoA synthetase alpha subunit were
participated in mitochondria metabolism, functional and
structural damage process caused by chronic ﬂuorosis. This
information will be very helpful for understanding the
molecular mechanisms of ﬂuorosis.
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